|
|
|
|
|
|
||
|
|
||||
|
|
||||
|
||||
Preclinical Experimental Therapeutics |
Department of Neurosurgery (S.Y., H.H., N.W., J.K.), Laboratory and Molecular Medicine (K.P.S.), Faculty of Medicine, Kagoshima University, Kagoshima 890-8520, Japan
1 Address correspondence and reprint requests to Shunichi Yokoyama, Department of Neurosurgery, Faculty of Medicine, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima 890-8520, Japan.
Abstract
We investigated the effect of epigallocatechin-gallate (EGCG), the main constituent of green tea polyphenols, on human glioblastoma cell lines U-373 MG and U-87 MG, rat glioma cell line C6, and rat nonfunctioning pituitary adenoma cell line MtT/E. Cell viability was determined by assay with 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT), and the extent of apoptosis was studied by `ow cytometric analysis. Apoptosis was also characterized by morphology using `uorescent microscopy. The role of insulin-like growth factor-I (IGF-I) was studied by assay with MTT, immunohistochemistry, and immunoradiometric assay. After 72-h exposure, a statistically significant loss of viability (P = < 0.0001) was observed at concentrations of 12.5, 25, 50, and 100 µg/ml in U-373 MG cells and U-87 MG cells. EGCG at concentrations of 50 µg/ml and higher significantly reduced the viability of C6 cells. EGCG inhibited viability of MtT/E cells only at a concentration of 100 µg/ml. Quantitative study by `ow cytometry demonstrated that lower doses of EGCG (12.5, 25, 50 µg/ml) induced apoptosis in U-373 MG, U-87 MG, and C6 cells; however, only the highest dose (100 µg/ml) induced apoptosis in MtT/E cells. Compared with other cell lines, MtT/E cells showed stronger IGF-I immunoreactivity. Neutralization of IGF-I with an antihuman IGF-I antibody reduced viability of the cell lines. It can be concluded that EGCG has an inhibitory effect on malignant brain tumors, and IGF-I may be involved in the effects of EGCG.
References
Ahmad, N., Feyes, D.K., Nieminen, A.L., Agarwal, R., and Mukhtar,
H. (1997) Green tea constituent epigallocatechin-3-gallate and
induction of apotosis and cell cycle arrest in human carcinoma cells.
J. Natl. Cancer Inst.
89,1881
-1886.
Ahn, H.Y., Hadizadeh, K.R., Seul, C., Yun, Y.P., Vetter, H., and
Sachinidis, A. (1999) Epigallocathechin-3 gallate selectively
inhibits the PDGF-BB-induced intracellular signalling transduction pathway in
vascular smooth muscle cells and inhibits transformation of sis-transfected
NIH 3T3 fibroblasts and human glioblastoma cells (A172). Mol. Biol.
Cell 10,1093
-1104.
Dunn, S.E., Hardman, R.A., Kari, F.W., and Barrett, J.C.
(1997) Insulin-like growth factor 1(IGF-1) alters drug
sensitivity of HBL 100 human breast cancer cells by inhibition of apoptosis
induced by diverse anticancer drugs. Cancer Res.
57,2687
-2693.
Flint, D.J., and Vernon, R.G. (1998) Effects of food restriction on the responses of the mammary gland and adipose tissue to prolactin and growth hormone in the lactating rat. J. Endocrinol. 156,299 -305.[Abstract]
Fujiki, H., Suganuma, M., Okabe, S., Sueoka, N., Komori, A., Sueoka, E., Kozu, T., Tada, Y., Suga, K., Imai, K., and Nakachi, K. (1998) Cancer inhibition by green tea. Mutat. Res. 402,307 -310.[ISI][Medline]
Hirano, H., Lopes, B.S., Laws, Jr., E.R., Asakura, T., Goto, M., Carpenter, J.E., Karns, L.R., and VandenBerg, S.R. (1999) Insulin-like growth factor-1 content and pattern of expression correlates with histopathologic grade in diffuesly infiltrating astrocytomas. Neuro-Oncology [serial online] Doc. 98-16, April 30, 1999. URL http://neuro-oncology.mc.duke.edu.Neuro-Oncology 1,109 -119.[Abstract]
Hsu, S.M., Raine, L., and Fanger, H. (1981) The use of antiavidin antibody and avidin-biotin-peroxidase complex in immunoperoxidase technics. Am. J. Clin. Pathol. 75,816 -821.[ISI][Medline]
Imai, K., Suga, K., and Nakachi, K. (1997) Cancer-preventive effects of drinking green tea among a Japanese population. Prev. Med. 26,769 -775.[CrossRef][ISI][Medline]
Inoue, K., Hattori, M., Sakai, T., Inukai, S., Fujimoto, N., and Ito, A. (1990) Establishment of a series of pituitary clonal cell lines differing in morphology, hormone secretion, and response to estrogen. Endocrinology 126,2313 -2320.[Abstract]
Katiyar, S.K., and Mukhtar, H. (1996) Tea in chemoprevention of cancer: Epidemiologic and experimental studies (review). Int. J. Oncol. 8,221 -238.
Lamm, G.M., and Christofori, G. (1998) Impairment of
survival factor function potentiates chemotherapy-induced apoptosis in tumor
cells. Cancer Res. 58,801
-807.
Lee, M.J., Wang, Z.Y., Li, H., Chen, L., Sun, Y., Gobbo, S., Balentine, D.A., and Yang, C.S. (1995) Analysis of plasma and urinary tea polyphenols in human subjects. Cancer Epidemiol. Biomarkers Prev. 4,393 -399.[Abstract]
Moncur, J.T., Park, J.P., Memoli, V.A., Mohandas, T.K., and Kinlaw,
W.B. (1998) The "Spot 14" gene resides on the
telomeric end of the 11q13 amplicon and is expressed in lipogenic breast
cancers: Implications for control of tumor metabolism. Proc. Natl.
Acad. Sci. U.S.A. 95,6989
-6994.
Nakachi, K., Suemasu, K., Suga, K., Takeo, T., Imai, K., and Higashi, Y. (1998) In`uence of drinking green tea on breast cancer malignancy among Japanese patients. Jpn. J. Cancer Res. 89,254 -261.[CrossRef][ISI][Medline]
Serenelli, G., Petturiti, G., Tognellini, R., Frascarelli, M., Sabbagh, M., and Viola-Magni, M.P. (1997) Apoptosis induced in glioma rat cells cultivated in presence of a medicinal infusion of green tea. Eur. J. Histochem. 41 (Suppl. 2), 85-86.
Singleton, J.R., Randolph, A.E., and Feldman, E.L.
(1996) Insulin-like growth factor I receptor prevents apoptosis
and enhances neuroblastoma tumori-genesis. Cancer Res.
56,4522
-4529.
Suga, K., Imai, K., Sueoka, N., and Nakachi, K. (1998) Phase I clinical trial with green tea tablets in a Japanese healthy population. Cancer Prev. Int. 3, 79-88.
Volpe, J.J., and Vagelos, P.R. (1976) Mechanisms and
regulation of biosynthesis of saturated fatty acids. Physiol.
Rev. 56,339
-417.
Watanabe, J., Kawabata, J., and Niki, R (1998) Isolation and identification of acetyl-CoA carboxylase inhibitors from green tea (Camellia sinensis). Biosci. Biotechnol. Biochem. 62,532 -534.[CrossRef][Medline]
Yokoyama, S., Stefaneanu, L., and Kovacs, K. (1997) Pituitary insulin-like growth factors. Endocr. Pathol. 8, 167-179.[ISI][Medline]
Yokoyama, S., Thapar, K., Kovacs, K., and Stefaneanu, L. (1998) Localization of insulin-like growth factor-II mRNA in human pituitary adenomas. Virchows Arch. 432,241 -246.[CrossRef][ISI][Medline]
Yoshizawa, S., Hjoriuchi, T., Fujiki, H., Yoshida, T., Okuda, T., and Sugimura, T. (1987) Antitumor promoting activity of (-)-epigallocatechin gallate, the main constituent of "tannin" in green tea. Phytother. Res. 1, 44-47.[CrossRef]
This article has been cited by other articles:
|
|
 |
|
  V. M. Adhami, F. Afaq, and H. Mukhtar Insulin-like growth factor-I axis as a pathway for cancer chemoprevention. Clin. Cancer Res., October 1, 2006; 12(19): 5611 - 5614. [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Wallace Integrative Tumor Board: Glioblastoma Multiforme: Nutritional and Botanical Approach Integr Cancer Ther, June 1, 2004; 3(2): 152 - 163. [PDF]
|
|
|
|
 |
|
 S. Hsu, W. B. Bollag, J. Lewis, Q. Huang, B. Singh, M. Sharawy, T. Yamamoto, and G. Schuster Green Tea Polyphenols Induce Differentiation and Proliferation in Epidermal Keratinocytes J. Pharmacol. Exp. Ther., July 1, 2003; 306(1): 29 - 34. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
